In silico Study of New Five-Membered Heterocyclic Derivatives Bearing (1,3,4-oxadiazole and 1,3,4-thiadiazole) As Promising Cyclooxygenase Inhibitors. AJPS. 2024;24(3):237-251. doi:10.32947/ajps.v24i3.1060